Jessa Hospital
jessazh.beTotal trials
85
Active
19
Phase 3
0
Total enrollment
45,127
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| p.P51S mutation | — | — | — | — | — | 1 | |
| PCIA with morphine | — | — | — | — | — | 1 |
Next readouts
- 2026-10-30
- 2027-12-31
Top conditions
- Surgery12
- DFNA95
- Anesthesia, Local5
- Analgesia4
- Covid194
- Coronary Artery Disease3
- Digital Health3
- COVID-193
Frequently asked questions about Jessa Hospital
- How many clinical trials does Jessa Hospital have on ClinicalTrials.gov?
- Jessa Hospital is listed as the lead sponsor on 85 clinical trials in ClinicalTrials.gov, 19 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Jessa Hospital's trials are in Phase 3?
- 0 of Jessa Hospital's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Jessa Hospital focus on?
- Jessa Hospital's most-studied conditions on ClinicalTrials.gov are Surgery, DFNA9, Anesthesia, Local, Analgesia, Covid19.
- When are Jessa Hospital's next clinical trial readouts?
- Jessa Hospital has 2 upcoming primary-completion readouts tracked here; the soonest is “Correlation of Radiological Lesions With Vestibular Function in Patients With Bilateral Vestibulopathy”, expected around 2026-10-30.